The emerging role of cell-free DNA as a molecular marker for cancer management

An increasing number of studies demonstrate the potential use of cell-free DNA (cfDNA) as a surrogate marker for multiple indications in cancer, including diagnosis, prognosis, and monitoring. However, harnessing the full potential of cfDNA requires (i) the optimization and standardization of preana...

Descripción completa

Detalles Bibliográficos
Autores principales: Bronkhorst, Abel Jacobus, Ungerer, Vida, Holdenrieder, Stefan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Special Issue on Liquid Biopsy & Biomarkers, Edited by Dr Michael Pfaffl
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425120/
https://www.ncbi.nlm.nih.gov/pubmed/30923679
http://dx.doi.org/10.1016/j.bdq.2019.100087

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425120/
https://www.ncbi.nlm.nih.gov/pubmed/30923679
http://dx.doi.org/10.1016/j.bdq.2019.100087

Ejemplares similares